Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Analytical Tool - Apoptosis in Oncology -' returned 68 results - Page 1 of 4  FEATURED RESULTS Drug Delivery in Cancer - Technologies, Markets and Companies Cancer Diagnostic Testing World Markets Antibody Drug Target Atlas in Oncology A Dictionary of Human Oncology: A Concise Guide to Tumors Oncology Review and Outlook 2010   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Analytical Tool - Apoptosis in Oncology   Bioseeker, Dec 2011 "Analytical Tool - Apoptosis in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in apoptotic drug development for the treatment of cancer Triple Analysis: Colorectal Cancer, Apoptosis and Peptides   Bioseeker, Dec 2011, Pages: 3579 on the following publication: A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market Part II: Apoptosis The apoptotic cancer drug report part comprises Triple Analysis: Leukemia, Apoptosis and Peptides   Bioseeker, Dec 2011, Pages: 3670 on the following publication: A Decision Support Tool for Optimizing The Leukemia Pipeline: From Research and Development to Market Part II: Apoptosis The apoptotic cancer drug report part comprises defined and up Triple Analysis: Lung Cancer, Apoptosis and Peptides   Bioseeker, Dec 2011, Pages: 3846 is based on the following publication: Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market Part II: Apoptosis The apoptotic cancer drug report part comprises defined Triple Analysis: Lymphoma, Apoptosis and Peptides   Bioseeker, Dec 2011, Pages: 3477 on the following publication: A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market Part II: Apoptosis The apoptotic cancer drug report part comprises defined and up Triple Analysis: Melanoma, Apoptosis and Peptides   Bioseeker, Dec 2011, Pages: 3300 Support Tool for Optimizing the Melanoma Pipeline: From Research and Development to Market Part II: Apoptosis The apoptotic cancer drug report part comprises defined and up to date development strategies Triple Analysis: Prostate Cancer, Apoptosis and Peptides   Bioseeker, Dec 2011, Pages: 3361 : A Decision Support Tool for Optimizing the Prostate Cancer Pipeline: From Research and Development to Market Part II: Apoptosis The apoptotic cancer drug report part comprises defined and up to date Triple Analysis: Apoptosis, Cancer Vaccines and Peptides   Bioseeker, Dec 2011, Pages: 3182 are commercialized. Key Topics Covered: Part I: Apoptosis 5.1 The Scope of this Report 33 6 Consider the Therapeutic Target Among Apoptotic Drugs in Oncology for the Highest Therapeutic Outcome and Return Triple Analysis: Colorectal Cancer, Apoptosis and Angiogenesis   Bioseeker, Jan 2012, Pages: 4377 : A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market Part II: Apoptosis The apoptotic cancer drug report part comprises defined and up to date Triple Analysis: Leukemia, Apoptosis and Angiogenesis   Bioseeker, Jan 2012, Pages: 4468 This triple analysis focuses on cancer drug development strategies in Leukemia and by the two mechanism/target/effect areas of Apoptosis and Angiogenesis. Each of these three individual parts Triple Analysis: Lung Cancer, Apoptosis and Angiogenesis   Bioseeker, Jan 2012, Pages: 4644 : A Decision Support Tool for Optimizing the Pipeline from Research To Market Part II: Apoptosis The apoptotic cancer drug report part comprises defined and up to date development strategies for 234 drugs Triple Analysis: Lymphoma, Apoptosis and Angiogenesis   Bioseeker, Jan 2012, Pages: 4275 This triple analysis focuses on cancer drug development strategies in Lymphoma and by the two mechanism/target/effect areas of Apoptosis and Angiogenesis. Each of these three individual parts Triple Analysis: Melanoma, Apoptosis and Angiogenesis   Bioseeker, Jan 2012, Pages: 4098 : From Research and Development to Market Part II: Apoptosis The apoptotic cancer drug report part comprises defined and up to date development strategies for 234 drugs in oncology within the portfolio Triple Analysis: Prostate Cancer, Apoptosis and Angiogenesis   Bioseeker, Jan 2012, Pages: 4159 Cancer Pipeline: From Research and Development to Market Part II: Apoptosis The apoptotic cancer drug report part comprises defined and up to date development strategies for 234 drugs in oncology within Triple Analysis: Apoptosis, Angiogenesis and Cancer Vaccines   Bioseeker, Jan 2012, Pages: 3980 are commercialized. Key Topics Covered: Part I: Apoptosis 5.1 The Scope of this Report 33 6 Consider the Therapeutic Target Among Apoptotic Drugs in Oncology for the Highest Therapeutic Outcome and Return Triple Analysis: Colorectal Cancer, Apoptosis and Antibodies   Bioseeker, Dec 2011, Pages: 4617 on the following publication: A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market Part II: Apoptosis The apoptotic cancer drug report part comprises Triple Analysis: Leukemia, Apoptosis and Antibodies   Bioseeker, Dec 2011, Pages: 4708 on the following publication: A Decision Support Tool for Optimizing The Leukemia Pipeline: From Research and Development to Market Part II: Apoptosis The apoptotic cancer drug report part comprises defined and up Triple Analysis: Lung Cancer, Apoptosis and Antibodies   Bioseeker, Dec 2011, Pages: 4884 is based on the following publication: Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market Part II: Apoptosis The apoptotic cancer drug report part comprises defined Triple Analysis: Lymphoma, Apoptosis and Antibodies   Bioseeker, Dec 2011, Pages: 4515 on the following publication: A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market Part II: Apoptosis The apoptotic cancer drug report part comprises defined and up Triple Analysis: Melanoma, Apoptosis and Antibodies   Bioseeker, Dec 2011, Pages: 4338 Support Tool for Optimizing the Melanoma Pipeline: From Research and Development to Market Part II: Apoptosis The apoptotic cancer drug report part comprises defined and up to date development strategies Results:  First -   Prev -   1 -   2 -   3 -   4 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network